Search Browse Earnings

VivoSim Labs, INC.

Nasdaq:VIVS

Biological Products, (No Diagnostic Substances)·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$109,000

-70.5% YoY

FY 2025

Adj. EBITDA

-$14.8M

-13583.5% margin

FY 2025

Net Income

-$14.7M

-13459.6% margin

FY 2025

EPS (Diluted)

-$19.25

FY 2025

Stock Price

$1.90

+1.4%

2026-03-09

52W Range

$1.41 – $5.63

P/E Ratio

-0.1x

Market Cap

$4.9M

Cash

$2.9M

FY 2025

Total Debt

—

Net Cash

$2.9M

FY 2025

Enterprise Value

$2.0M

Debt / EBITDA

0.2x

FY 2025

EV / EBITDA

-0.1x

Employees

—